Finance

Lists
Why is MDCX down 4.67%?
Dive Deeper
MDCX:NASDAQ
Medicus Pharma Ltd
$0.16
-4.67%
(-0.0078) 1D
$0.16
+0.19% (+0.00030)
Pre-market
Closed: Oct 6, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDCX...
Open
$0.17
High
$0.17
Low
$0.16
Mkt. cap
9.53M
Avg. vol.
7.46M
Volume
11.09K
52-wk high
$2.78
52-wk low
$0.14
EPS
-$2.45
Shares outstanding
63.18M
No. of employees
16
Open
$0.17
High
$0.17
Low
$0.16
Mkt. cap
9.53M
Avg. vol.
7.46M
Volume
11.09K
52-wk high
$2.78
52-wk low
$0.14
EPS
-$2.45
Shares outstanding
63.18M
No. of employees
16
News stories
From web sources and news partners
About Medicus Pharma Ltd
CEO-
Employees16
Founded2008
HeadquartersConshohocken, Pennsylvania, United States
SectorBiotechnology
Websitemedicuspharma.com
Analyst ratings
Based on 3 analysts giving stock ratings to MDCX in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for MDCX in the last 3 months.
Highest
Current $0.16
$9.00 (+5,553.27%)
Average
$4.00 (+2,412.56%)
Lowest
$1.00 (+528.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Venezia
Alliance Global Partners
Buy
Maintained
$1.00
+528.1%
09/14/2026
Scott Henry
Alliance Global Partners
Buy
Maintained
$1.00
+528.1%
09/14/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$2.00
+1,156.3%
09/10/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
$9.00
+5,553.3%
09/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.68M
2.59M
2.70M
4.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.02M
5.20M
5.89M
6.57M
Operating expense
6.71M
7.79M
8.60M
11.48M
Total operating expenses
6.71M
7.79M
8.60M
11.48M
Operating income
-6.71M
-7.79M
-8.60M
-11.48M
Other non operating income
-4.95M
-6.88M
-
-
EBT including unusual items
-20.94M
-15.07M
-9.04M
-11.68M
EBT excluding unusual items
-11.65M
-14.95M
-8.92M
-11.68M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20.94M
-15.07M
-9.04M
-11.62M
Net profit margin
-
-
-
-
Earnings per share
-1.09
-0.44
-0.30
-0.21
Interest and investment income
11.57K
-
56.56K
-
Interest expense
-
-272.82K
-374.71K
-205.64K
Net interest expenses
11.57K
-272.82K
-318.15K
-205.64K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps